Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Niraj Jha and Shreesh Ojha.
Niraj Jha
Connection Strength
2.168
Shreesh Ojha
  1. ß-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol. 2021; 12:590201.
    View in: PubMed
    Score: 0.945
  2. Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19. Front Pharmacol. 2021; 12:603997.
    View in: PubMed
    Score: 0.238
  3. Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19. Front Plant Sci. 2020; 11:601335.
    View in: PubMed
    Score: 0.232
  4. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon. 2021 Feb; 7(2):e05990.
    View in: PubMed
    Score: 0.232
  5. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209.
    View in: PubMed
    Score: 0.231
  6. Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? Heliyon. 2021 Jan; 7(1):e05703.
    View in: PubMed
    Score: 0.229
  7. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul; 7(7):e07635.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.